Intrinsic and acquired resistance to cetuximab in colorectal cancer patients

被引：0
|
作者：
Bray, Steven M.
Lee, Jeeyun
Kim, Seung Tae
Ebert, Philip J.
Calley, John N.
Wulur, Isabella H.
Gopalappa, Thejaswini
Wong, Swee Seong
Qian, Hui-Rong
Ting, Jason C.
Liu, Jiangang
Willard, Melinda D.
Aggarwal, Amit
Novosiadly, Ruslan D.
Kim, Hee-Cheol
Reinhard, Christoph
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4104
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
    Steven M. Bray
    Jeeyun Lee
    Seung Tae Kim
    Joon Young Hur
    Philip J. Ebert
    John N. Calley
    Isabella H. Wulur
    Thejaswini Gopalappa
    Swee Seong Wong
    Hui-Rong Qian
    Jason C. Ting
    Jiangang Liu
    Melinda D. Willard
    Ruslan D. Novosiadly
    Young Suk Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Amit Aggarwal
    Hee Cheol Kim
    Christoph Reinhard
    Scientific Reports, 9
  • [2] Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
    Bray, Steven M.
    Lee, Jeeyun
    Kim, Seung Tae
    Hur, Joon Young
    Ebert, Philip J.
    Calley, John N.
    Wulur, Isabella H.
    Gopalappa, Thejaswini
    Wong, Swee Seong
    Qian, Hui-Rong
    Ting, Jason C.
    Liu, Jiangang
    Willard, Melinda D.
    Novosiadly, Ruslan D.
    Park, Young Suk
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Aggarwal, Amit
    Kim, Hee Cheol
    Reinhard, Christoph
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
    Johnson, Radia M.
    Qu, Xueping
    Lin, Chu-Fang
    Huw, Ling-Yuh
    Venkatanarayan, Avinashnarayan
    Sokol, Ethan
    Ou, Fang-Shu
    Ihuegbu, Nnamdi
    Zill, Oliver A.
    Kabbarah, Omar
    Wang, Lisa
    Bourgon, Richard
    de Sousa e Melo, Felipe
    Bolen, Chris
    Daemen, Anneleen
    Venook, Alan P.
    Innocenti, Federico
    Lenz, Heinz-Josef
    Bais, Carlos
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer
    Radia M. Johnson
    Xueping Qu
    Chu-Fang Lin
    Ling-Yuh Huw
    Avinashnarayan Venkatanarayan
    Ethan Sokol
    Fang-Shu Ou
    Nnamdi Ihuegbu
    Oliver A. Zill
    Omar Kabbarah
    Lisa Wang
    Richard Bourgon
    Felipe de Sousa e Melo
    Chris Bolen
    Anneleen Daemen
    Alan P. Venook
    Federico Innocenti
    Heinz-Josef Lenz
    Carlos Bais
    Nature Communications, 13
  • [5] Characterization of EGFR ectodomain mutation in acquired resistance to cetuximab in colorectal cancer
    Joshi, Neeraj
    Deal, Ramona Graves
    Bogatcheva, Galina
    Higginbotham, James N.
    Ramirez, Marisol
    Brown, Benjamin P.
    Liu, Qi
    Meiler, Jens
    Singh, Bhuminder
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
    Santini, D.
    Vincenzi, B.
    Addeo, R.
    Garufi, C.
    Masi, G.
    Scartozzi, M.
    Mancuso, A.
    Frezza, A. M.
    Venditti, O.
    Imperatori, M.
    Schiavon, G.
    Bronte, G.
    Cicero, G.
    Recine, F.
    Maiello, E.
    Cascinu, S.
    Russo, A.
    Falcone, A.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2313 - 2318
  • [7] Molecular predictors of cetuximab resistance in colorectal cancer patients
    Finocchiaro, G.
    Cappuzz, F.
    Toschi, L.
    Rossj, E.
    Janne, P. A.
    Roncalli, M.
    Ligorio, C.
    Rimassa, L.
    Santoro, A.
    Varella-Garcia, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 141 - 141
  • [8] Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab
    Li, Zongcheng
    Chen, Yuling
    Ren, Wu
    Hu, Shuofeng
    Tan, Zhaoli
    Wang, Yan
    Chen, Yaowen
    Zhang, Jian
    Wu, Jiaqi
    Li, Tingting
    Xu, Jianming
    Ying, Xiaomin
    CANCER GENOMICS & PROTEOMICS, 2019, 16 (03) : 207 - 219
  • [9] PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
    Xu, Jian-Ming
    Wang, Yan
    Wang, You-Liang
    Wang, Yan
    Liu, Tao
    Ni, Ming
    Li, Man-Sheng
    Lin, Li
    Ge, Fei-Jiao
    Gong, Chun
    Gu, Jun-Yan
    Jia, Ru
    Wang, He-Fei
    Chen, Yu-Ling
    Liu, Rong-Rui
    Zhao, Chuan-Hua
    Tan, Zhao-Li
    Jin, Yang
    Zhu, Yun-Ping
    Ogino, Shuji
    Qian, Zhi-Rong
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4602 - 4616
  • [10] CetuximabDevelopment of acquired cetuximab-resistance in colorectal-cancer: 2 case reports
    Reactions Weekly, 2017, 1644 (1) : 78 - 78
12345